Spots Global Cancer Trial Database for lovaza
Every month we try and update this database with for lovaza cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue | NCT01784042 | Breast Cancer | Placebo Lovaza Dietary energy ... | 30 Years - 55 Years | Milton S. Hershey Medical Center | |
| QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | NCT03169764 | Head and Neck S... | Avelumab Bevacizumab Capecitabine Cetuximab Cisplatin cyclophosphamid... 5-Fluorouracil ... fulvestrant leucovorin nab-paclitaxel nivolumab Lovaza Stereotactic Bo... ALT-803 ETBX-011 ETBX-021 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK | 18 Years - | ImmunityBio, Inc. | |
| QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | NCT03387098 | Pancreatic Canc... | Aldoxorubicin H... ALT-803 ETBX-011 GI-4000 haNK for infusi... avelumab bevacizumab Capecitabine Cyclophosphamid... Fluorouracil Leucovorin nab-Paclitaxel lovaza Oxaliplatin SBRT | 18 Years - | ImmunityBio, Inc. | |
| QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors | NCT03169738 | Non-small Cell ... | avelumab Bevacizumab Capecitabine Cisplatin cyclophosphamid... 5-Fluorouracil ... fulvestrant leucovorin nab paclitaxel nivolumab Lovaza Oxaliplatin Stereotactic Bo... ALT-803 ETBX-011 ETBX-021 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK | 18 Years - | ImmunityBio, Inc. | |
| QUILT-3.049: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Combination Immunotherapy in Subjects With TNBC Who Have Progressed on or After Anthracycline-based Chemotherapy | NCT03175666 | Triple Negative... | avelumab bevacizumab capecitabine cisplatin cyclophosphamid... 5-Fluorouracil Leucovorin nab-paclitaxel Lovaza Stereotactic Bo... ALT-803 ETBX-011 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK | 18 Years - | ImmunityBio, Inc. | |
| QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors | NCT03169738 | Non-small Cell ... | avelumab Bevacizumab Capecitabine Cisplatin cyclophosphamid... 5-Fluorouracil ... fulvestrant leucovorin nab paclitaxel nivolumab Lovaza Oxaliplatin Stereotactic Bo... ALT-803 ETBX-011 ETBX-021 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK | 18 Years - | ImmunityBio, Inc. | |
| QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy | NCT03197571 | Urothelial Carc... | avelumab bevacizumab capecitabine cisplatin cyclophosphamid... 5Fluorouracil (... fulvestrant leucovorin nab-paclitaxel Lovaza Stereotactic Bo... ALT-803 ETBX-011 ETBX-021 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK | 18 Years - | ImmunityBio, Inc. | |
| QUILT-3.050: NANT Colorectal Cancer (CRC) Vaccine: Combination Immunotherapy in Subjects With Recurrent or Metastatic CRC | NCT03169777 | Colorectal Canc... | avelumab bevacizumab capecitabine cetuximab Cyclophosphamid... 5-Fluorouracil ... fulvestrant leucovorin nab paclitaxel nivolumab Lovaza oxaliplatin Stereotactic Bo... ALT-803 ETBX-011 ETBX-021 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK | 18 Years - | ImmunityBio, Inc. | |
| QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors | NCT03169738 | Non-small Cell ... | avelumab Bevacizumab Capecitabine Cisplatin cyclophosphamid... 5-Fluorouracil ... fulvestrant leucovorin nab paclitaxel nivolumab Lovaza Oxaliplatin Stereotactic Bo... ALT-803 ETBX-011 ETBX-021 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK | 18 Years - | ImmunityBio, Inc. | |
| Dietary Energy Restriction and Omega-3 Fatty Acids on Mammary Tissue | NCT01784042 | Breast Cancer | Placebo Lovaza Dietary energy ... | 30 Years - 55 Years | Milton S. Hershey Medical Center | |
| QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | NCT03329248 | Pancreatic Canc... | ALT-803 ETBX-011 GI-4000 haNK for infusi... avelumab bevacizumab Capecitabine Cyclophosphamid... Fluorouracil Leucovorin nab-Paclitaxel lovaza Oxaliplatin SBRT | 18 Years - | ImmunityBio, Inc. | |
| QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy | NCT03387098 | Pancreatic Canc... | Aldoxorubicin H... ALT-803 ETBX-011 GI-4000 haNK for infusi... avelumab bevacizumab Capecitabine Cyclophosphamid... Fluorouracil Leucovorin nab-Paclitaxel lovaza Oxaliplatin SBRT | 18 Years - | ImmunityBio, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
